<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Medicine Decoded]]></title><description><![CDATA[Medicine Decoded is an online platform designed to help students master medical concepts with clear, accessible study resources.]]></description><link>https://www.medicinedecoded.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Wed, 29 Jul 2026 19:23:36 GMT</lastBuildDate><atom:link href="https://www.medicinedecoded.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[FDA Approves Zidesamtinib (Jideytro): A High-Yield Precision Oncology Case You Need to Know]]></title><description><![CDATA[On July 22, 2026, the FDA approved zidesamtinib (Jideytro) for adults with locally advanced or metastatic ROS1-fusion positive non-small cell lung cancer (NSCLC) who had already received at least one prior ROS1 tyrosine kinase inhibitor (TKI). Approval was based on the single-arm ARROS-1 trial (NCT05118789; efficacy population n=117), using RECIST v1.1 overall response rate (ORR) and duration of response (DOR) as primary endpoints. For medical students and future physicians, this isn't just...]]></description><link>https://www.medicinedecoded.com/post/fda-approves-zidesamtinib-jideytro-a-high-yield-precision-oncology-case-you-need-to-know</link><guid isPermaLink="false">6a690da394da60ff381a6314</guid><pubDate>Tue, 28 Jul 2026 21:35:08 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/d71c02_d2eda4e1dc4a481ea2621c732d5995f4~mv2.png/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Medicine Decoded</dc:creator></item></channel></rss>